Company news

The field of Hepato-Pancreato-Biliary (HPB) surgery in Vietnam has achieved remarkable advancements in recent years, driven by the development of modern techniques such as minimally invasive surgery, laparoscopic procedures, liver transplantation, and advanced HPB interventions. Demonstrating its commitment to supporting medical innovation, HDN proudly participated in the conference as a Diamond Sponsor.

Continuing its series of programs organized in collaboration with Relisys, HDN Investment Joint Stock Company recently held another successful scientific workshop at the Cardiovascular Center of E Hospital in Vietnam.

Following the success of the scientific workshop held at 108 Military Central Hospital, 19-8 Hospital became the next destination in this series jointly organized by HDN Investment Joint Stock Company and Relisys Medical Devices (India).

Through HDN Investment Joint Stock Company, the signing ceremony for the procurement and installation of advanced diagnostic imaging systems between GE HealthCare and Hong Ha General Hospital was successfully held.

The event marked not only a major international scientific forum but also an important milestone highlighting the transformation of one of Vietnam’s leading special-class hospitals in the era of modern medicine.

Over the past two decades, HDN has steadily strengthened its position by building on core values centered around product quality, professional service, and the trust of customers and strategic partners.

As a strategic distribution partner of GE HealthCare in Vietnam, HDN’s participation reaffirmed the company’s strong market development capabilities, implementation expertise, and long-term commitment to accompanying GE HealthCare in delivering advanced medical technologies to healthcare facilities across Vietnam.

The field of Hepato-Pancreato-Biliary (HPB) surgery in Vietnam has achieved remarkable advancements in recent years, driven by the development of modern techniques such as minimally invasive surgery, laparoscopic procedures, liver transplantation, and advanced HPB interventions. Demonstrating its commitment to supporting medical innovation, HDN proudly participated in the conference as a Diamond Sponsor.

Last week, HDN Investment Joint Stock Company, in collaboration with Relisys Medical Devices, successfully organized a specialized scientific workshop at 108 Military Central Hospital under the theme “Latest Innovations in Transcatheter Aortic Valve Implantation (TAVI)”.

Through HDN Investment Joint Stock Company, the signing ceremony for the procurement and installation of advanced diagnostic imaging systems between GE HealthCare and Hong Ha General Hospital was successfully held.